Premenstrual dysphoric disorder (PMDD) is a serious psychoemotional disorder that occurs in women during the premenstrual syndrome phase. This disease is characterized by a wide range of symptoms reflecting both affective and physiological changes, the latter of which can create significant difficulties in everyday life. PMDD symptoms include, but are not limited to, severe depression, anxiety, irritability, emotional lability, as well as physical manifestations such as headaches, sleep disorders, and others. The nature of this disorder is not fully understood, and its pathogenesis, associated with changes in hormone levels, changes in neurotransmitters, and genetic predisposition, continues to be the subject of active research. Diagnosis of PMDD requires a comprehensive approach and excludes other possible disorders, and also requires an understanding of the impact on a woman's quality of life.
History of the disease and interesting historical facts
The concept of premenstrual dysphoric disorder began to emerge in the late 20th century. In 1987, PMDD was included in the DSM-III classification as a separate entity, thus declaring its significance in psychiatry. Research on premenstrual disorders can be traced back to ancient times, when historical records mentioned changes in women’s mood and behavior depending on the menstrual cycle. In the 19th century, such disorders were considered “female hysteria,” which reflected a lack of understanding of the pathology. Only with the assessment of the menstrual cycle as a physiological process were attempts made to study PMDD more comprehensively.
Epidemiology
According to current data, premenstrual dysphoric disorder affects approximately 3-8% women of reproductive age. Epidemiological studies show that the severity of symptoms can vary significantly. The prevalence of this disorder is associated with age, with the highest number of cases observed in women aged 25 to 40 years. Interestingly, PMDD is more common in women with a history of depressive disorders, anxiety disorders and other mental illnesses. Prevalence and diagnostic assessment allows us to identify the problem at an early stage and improve the quality of life of women suffering from this disorder.
Genetic predisposition to this disease
Research suggests that there is a significant genetic predisposition to premenstrual dysphoric disorder. In particular, different variants of genes responsible for serotonin metabolism, such as the 5-HTTPL gene polymorphism, could influence susceptibility to PMDD. Interesting data have been obtained in large genetic studies and family analyses, showing that the presence of PMDD cases in the family increases the chance of developing this disorder. Mutations in other genes responsible for hormonal regulation may also play a role in the pathogenesis of PMDD. Despite the presence of a genetic predisposition, the influence of the environment and external factors remains no less significant in the formation of this disorder.
Risk factors for the development of this disease
Risk factors for premenstrual dysphoric disorder include:
- Heredity. Presence of cases of PMDD or other mental disorders in the family.
- Unfavorable life circumstances. Stressful situations, illnesses, loss of loved ones.
- Hormonal changes. Changes in the menstrual cycle, such as menstrual irregularities.
- Mental disorders. A history of depression and anxiety disorders may contribute to a more severe course of PMDD.
- Smoking: Some studies suggest that women who smoke may have a higher risk of developing PMDD.
Chemical and physical risk factors also play a role, including substance abuse, lack of sleep, and low levels of physical activity.
Diagnosis of this disease
Diagnosis of premenstrual dysphoric disorder is based on a comprehensive approach and includes the following steps:
- Main symptoms: The main symptoms of PMDD are depressed mood, increased irritability, feelings of hopelessness, physical symptoms such as headaches and fatigue.
- Laboratory tests: Blood tests for hormone levels, electrolytes, and thyroid function can help identify functional disorders.
- Radiological examinations. In some cases, MRI or ultrasound may be required to rule out organic diseases.
- Other types of diagnostics: Psychological testing and mood assessment on specialized scales can be used to more accurately determine the severity of the disorder.
- Differential diagnosis: It is important to exclude other mental disorders, particularly depression and anxiety disorders, which may have similar symptoms.
Treatment
Treatment for premenstrual dysphoric disorder should be comprehensive and tailored to each patient. It may include:
- General treatment. Lifestyle changes, including physical activity, diet, and daily routine.
- Pharmacological treatment. Use of antidepressants such as SSRIs (selective serotonin reuptake inhibitors) or hormonal drugs such as oral contraceptives.
- Surgical treatment. In rare cases, surgery may be considered, for example in severe cases of the disorder where medications are ineffective.
- Other treatments: Psychotherapy, including cognitive behavioral therapy, may be effective in improving emotional well-being.
List of medications used to treat this disease
Some of the most commonly used medications for the treatment of PMDD include:
- Fluoxetine (Prozac)
- Sertraline (Zoloft)
- Paroxetine (Paxil)
- Escitalopram (Lexapro)
- Duloxetine (Cymbalta)
- Combined hormonal drugs
- Gabapentin (Neurontin) for pain symptom control
Disease monitoring
Monitoring the condition of patients suffering from PMDD includes regular assessment of the severity of symptoms and quality of life. This allows us to determine the effectiveness of treatments and adjust therapy. Attention should be paid to:
- Control stages. Regular visits to the doctor to assess the patient's condition.
- Prognosis: With adequate treatment, the diagnosis can significantly improve quality of life.
- Complications: Neglecting treatment can lead to relapse of depressive episodes and deterioration of general health.
Age-related features of the disease
Premenstrual dysphoric disorder can manifest itself differently depending on the woman’s age. In the younger generation, starting in adolescence, the symptoms may be more pronounced due to hormonal changes. In women of reproductive age, PMDD often manifests itself under stress, against the background of family and professional problems. With age, especially during the transition to menopause, the symptoms may change, and many women note their weakening after the end of menstruation. However, in some patients, PMDD may continue into the climacteric period.
Questions and Answers
- What is premenstrual dysphoric disorder? PMDD is a serious psychoemotional disorder that occurs in women during the premenstrual period and is characterized by pronounced depressive and anxiety symptoms.
- How common is PMDD? PMDD affects between 3 and 8% women of reproductive age, most often among those with a history of mental disorders.
- How is premenstrual dysphoric disorder treated? Treatment may include lifestyle changes, psychotherapy, medications, and, in rare cases, surgery.
- What are the signs of PMDD? The most obvious symptoms include depression, increased irritability, emotional vulnerability, as well as physical manifestations such as headaches and fatigue.
- Can PMDD go away after menopause? For many women, symptoms may ease or disappear with menopause, but in some cases the disorder may continue.